# Sym004 in Patients With Advanced Solid Tumors

> **NCT01117428** · PHASE1,PHASE2 · COMPLETED · sponsor: **Symphogen A/S** · enrollment: 111 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Sym004

## Key facts

- **NCT ID:** NCT01117428
- **Lead sponsor:** Symphogen A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2015-02
- **Final completion:** 2015-05
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2018-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01117428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01117428, "Sym004 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01117428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*